According to new data from the European Patent Office, the medtech sector remains a major point of innovation in Europe, with 13,833 patent applications in the sector in 2019.
This represents approximately a 1 per cent increase from 2018, which saw 13,707 filings. While this means that growth has slowed slightly from the two years prior to 2019, it has seen medtech become Europe’s second largest source of patents behind digital communications.
Medtech in the UK has seen particular growth, outstripping the global growth of medtech filings, with filings in the UK up 3.1 per cent from 2018.
Biotechnology and pharmaceuticals have also seen increases in patents filed in 2019, going up by around 1.6 per cent and 4.4 per cent respectively.
According to Dr Thomas Prock of intellectual property firm Marks & Clerk: “The latest figures from the EPO reveal the scale of innovation in the medtech sector, and the increasingly important role medtech has in delivering better, more intelligent healthcare.”
“The healthcare challenges of the 21st century – whether it’s ageing populations or antimicrobial resistance – need smart solutions, and medtech is key in delivering better diagnostic and sensory technologies which empower people to take charge of their own health.”